Table 4.
Outcomes | No. of trials (PAV/NAVA) | Total sample size | Summary estimates (95% confidence intervals) | Heterogeneity | p value (test for subgroup difference) | ||
---|---|---|---|---|---|---|---|
Q | df | I2 (%) | |||||
AI as continuous outcome | PAV, 1 | 32 | WMD − 0.45 (− 1.00, 0.10) | 0.00 | 0 | – | 0.06 |
NAVA, 7 | 268 | WMD − 3.06 (− 5.74, − 0.39) | 35.53 | 6 | 83.1 | ||
AI > 10% | PAV, 2 | 110 | RR 0.06 (0.01, 0.46) | 0.00 | 1 | 0.0 | 0.57 |
NAVA, 5 | 151 | RR 0.20 (0.05, 0.92) | 15.47 | 4 | 59.5 | ||
Weaning failure | PAV, 3 | 317 | RR 0.44 (0.26, 0.75) | 0.60 | 2 | 0.0 | NA |
Duration of mechanical ventilation | PAV, 3 | 318 | WMD − 2.25 (− 3.86, − 0.65) | 3.13 | 2 | 36.5 | 0.16 |
NAVA, 2 | 161 | WMD − 0.03 (− 2.66, 2.61) | 0.03 | 1 | 0.0 |
AI asynchrony index, RR risk ratio, WMD weighed mean difference